Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Heather Calendrillo

Nurse Practitioner, Pediatrics Babylon, NY Nurse Practitioner

NPI 1528253101 CMS profile 10551824

655 Deer Park Ave, Babylon, NY 11702

Open in the dashboard

General payments

$3,862

178 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Heather Calendrillo of Babylon, NY is reported in the CMS Open Payments database as having received $3,862 across 178 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Nurse Practitioner, Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,468 55
2024 General $952 41
2023 General $901 51
2022 General $361 22
2021 General $180 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Heather Calendrillo
  • Nurse Practitioner, Pediatrics median
  • Middle half of Nurse Practitioner, Pediatrics
  • National median

In program year 2025, general payments to Heather Calendrillo were reported at $1,468. Among 7,458 Nurse Practitioner, Pediatrics profiles paid that year, the median was $93 and the middle half received between $35 and $201.

Show as a table
Year Heather Calendrillo Nurse Practitioner, Pediatrics median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $180 $60 $23–$142 $132
2022 $361 $72 $27–$161 $149
2023 $901 $89 $35–$185 $160
2024 $952 $93 $34–$199 $164
2025 $1,468 $93 $35–$201 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Regeneron Healthcare Solutions, Inc. $729 26 payments
  2. Genzyme Corporation $707 27 payments
  3. Corium, Inc. $276 21 payments
  4. Supernus Pharmaceuticals, Inc. $270 15 payments
  5. Baxter Healthcare $152 8 payments
  6. Tolmar, Inc. $135 4 payments
  7. Abbott Laboratories $135 7 payments
  8. ACADIA Pharmaceuticals Inc $105 4 payments
  9. GlaxoSmithKline, LLC. $105 6 payments
  10. Tandem Diabetes Care, Inc. $97 5 payments
  11. Other $1,152 55 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,828 177 payments
  2. Education $34 1 payment
Products named General payments · program years 2021–2025
  1. DUPIXENT Immunology $800 31 payments
  2. DUPIXENT Immunology And Inflammation $424 15 payments
  3. DUPIXENT Inflammation And Immunology $304 11 payments
  4. Azstarys $276 21 payments
  5. QELBREE Psychology $168 10 payments
  6. FENSOLVI $152 5 payments
  7. FreeStyle Libre 3 $135 7 payments
  8. DAYBUE $105 4 payments
  9. NUCALA $105 6 payments
  10. Qelbree Viloxazine Hydrochloride $102 5 payments
  11. Other $1,292 63 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

178 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record